DE69908951D1 - Kristallformen von osanetant - Google Patents

Kristallformen von osanetant

Info

Publication number
DE69908951D1
DE69908951D1 DE69908951T DE69908951T DE69908951D1 DE 69908951 D1 DE69908951 D1 DE 69908951D1 DE 69908951 T DE69908951 T DE 69908951T DE 69908951 T DE69908951 T DE 69908951T DE 69908951 D1 DE69908951 D1 DE 69908951D1
Authority
DE
Germany
Prior art keywords
osanetant
crystal forms
crystal
forms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69908951T
Other languages
English (en)
Other versions
DE69908951T2 (de
Inventor
Alain Alcade
Gilles Anne-Archard
Patrick Grosclaude
Olivier Monnier
Jerome Roche
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo SA filed Critical Sanofi Synthelabo SA
Application granted granted Critical
Publication of DE69908951D1 publication Critical patent/DE69908951D1/de
Publication of DE69908951T2 publication Critical patent/DE69908951T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE69908951T 1998-08-05 1999-08-03 Kristallformen von osanetant Expired - Fee Related DE69908951T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9810107A FR2782082B3 (fr) 1998-08-05 1998-08-05 Formes cristallines de (r)-(+)-n-[[3-[1-benzoyl-3-(3,4- dichlorophenyl)piperidin-3-yl]prop-1-yl]-4-phenylpiperidin-4 -yl]-n-methylacetamide (osanetant) et procede pour la preparation dudit compose
FR9810107 1998-08-05
PCT/FR1999/001914 WO2000007987A1 (fr) 1998-08-05 1999-08-03 Formes cristallines du osanetant

Publications (2)

Publication Number Publication Date
DE69908951D1 true DE69908951D1 (de) 2003-07-24
DE69908951T2 DE69908951T2 (de) 2004-05-19

Family

ID=9529458

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69908951T Expired - Fee Related DE69908951T2 (de) 1998-08-05 1999-08-03 Kristallformen von osanetant

Country Status (32)

Country Link
US (1) US7041679B2 (de)
EP (1) EP1102747B1 (de)
JP (1) JP3807938B2 (de)
KR (1) KR100571944B1 (de)
CN (1) CN1114592C (de)
AR (1) AR019953A1 (de)
AT (1) ATE243197T1 (de)
AU (1) AU748177B2 (de)
BR (1) BR9913357A (de)
CA (1) CA2339007A1 (de)
CO (1) CO5070576A1 (de)
DE (1) DE69908951T2 (de)
DK (1) DK1102747T3 (de)
DZ (1) DZ3074A1 (de)
EA (1) EA003205B1 (de)
EE (1) EE04274B1 (de)
ES (1) ES2200535T3 (de)
FR (1) FR2782082B3 (de)
HK (1) HK1035535A1 (de)
HU (1) HUP0103134A3 (de)
IS (1) IS5821A (de)
MY (1) MY121447A (de)
NO (1) NO320645B1 (de)
NZ (1) NZ509561A (de)
PL (1) PL345999A1 (de)
PT (1) PT1102747E (de)
SK (1) SK1742001A3 (de)
TR (1) TR200100261T2 (de)
TW (1) TW527354B (de)
UA (1) UA72890C2 (de)
WO (1) WO2000007987A1 (de)
YU (1) YU8601A (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0100902D0 (sv) * 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
SE0202539D0 (sv) 2002-08-27 2002-08-27 Astrazeneca Ab Compounds
SE0401762D0 (sv) * 2004-07-05 2004-07-05 Astrazeneca Ab Novel compounds
US7648992B2 (en) * 2004-07-05 2010-01-19 Astrazeneca Ab Hydantoin derivatives for the treatment of obstructive airway diseases
SE0403086D0 (sv) * 2004-12-17 2004-12-17 Astrazeneca Ab Compounds
SE0403085D0 (sv) * 2004-12-17 2004-12-17 Astrazeneca Ab Novel componds
TW200800954A (en) * 2006-03-16 2008-01-01 Astrazeneca Ab Novel crystal modifications
TW200831488A (en) * 2006-11-29 2008-08-01 Astrazeneca Ab Novel compounds
TW202317533A (zh) * 2021-07-02 2023-05-01 美商雅斯治療公司 奧沙奈坦(osanetant)之固體形式

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2719311B1 (fr) * 1994-03-18 1998-06-26 Sanofi Sa Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic.
JPH1053576A (ja) * 1996-06-07 1998-02-24 Eisai Co Ltd 塩酸ドネペジルの多形結晶およびその製造法
JP2000515534A (ja) * 1996-08-05 2000-11-21 スミスクライン・ビーチャム・ソシエタ・ペル・アチオニ ３，３―二置換ピペリジンの製造方法
US6040316A (en) * 1996-09-16 2000-03-21 Warner-Lambert Company 3-alkyl-3-phenyl-piperidines
FR2757543B1 (fr) * 1996-12-23 1999-04-02 Sanofi Sa Procede pour la cristallisation d'un derive de tetrahydropyridine et formes cristallines ainsi obtenues

Also Published As

Publication number Publication date
AU748177B2 (en) 2002-05-30
CN1314888A (zh) 2001-09-26
SK1742001A3 (en) 2001-11-06
DE69908951T2 (de) 2004-05-19
NO20010553L (no) 2001-04-05
NZ509561A (en) 2002-10-25
YU8601A (sh) 2003-07-07
KR100571944B1 (ko) 2006-04-18
CA2339007A1 (en) 2000-02-17
CO5070576A1 (es) 2001-08-28
PL345999A1 (en) 2002-01-14
HUP0103134A2 (en) 2002-06-29
CN1114592C (zh) 2003-07-16
EE04274B1 (et) 2004-04-15
WO2000007987A1 (fr) 2000-02-17
ATE243197T1 (de) 2003-07-15
KR20010072220A (ko) 2001-07-31
EA200100096A1 (ru) 2001-08-27
IS5821A (is) 2001-01-23
EP1102747A1 (de) 2001-05-30
UA72890C2 (en) 2005-05-16
EE200100070A (et) 2002-06-17
FR2782082B3 (fr) 2000-09-22
JP2002522419A (ja) 2002-07-23
BR9913357A (pt) 2001-05-15
PT1102747E (pt) 2003-09-30
TR200100261T2 (tr) 2001-06-21
AU5168599A (en) 2000-02-28
AR019953A1 (es) 2002-03-27
EP1102747B1 (de) 2003-06-18
HUP0103134A3 (en) 2003-03-28
HK1035535A1 (en) 2001-11-30
EA003205B1 (ru) 2003-02-27
FR2782082A1 (fr) 2000-02-11
NO20010553D0 (no) 2001-02-01
US7041679B2 (en) 2006-05-09
JP3807938B2 (ja) 2006-08-09
DZ3074A1 (fr) 2004-07-20
ES2200535T3 (es) 2004-03-01
MY121447A (en) 2006-01-28
US20040044215A1 (en) 2004-03-04
DK1102747T3 (da) 2003-09-29
TW527354B (en) 2003-04-11
NO320645B1 (no) 2006-01-09

Similar Documents

Publication Publication Date Title
DE69928195D1 (de) Komplettierung von Untrerdruck-Bohrlöchern
DE69941116D1 (de) G von gdf-8
CY2012029I2 (el) Nεα μορφη της 5-ομεπραζολης
ATE322519T1 (de) Rheologieänderung von elastomeren
DE59905858D1 (de) Verwendung von pit-emulsionen
ID24481A (id) Gastrokinetik monosiklik benzamida dari derivat-3-atau-tersubstitusi 4-(aminometil)-piperidin
DE69913553D1 (de) Konfigurierung von systemeinheiten
IT1304793B1 (it) Miscela di stabilizzanti
ATE231521T1 (de) Kristalline formen von eto2c-ch2-(r)cgl-aze-pab- oh
ID24458A (id) Modifikasi rheologi in-sito poliolefin
DE50012379D1 (de) Verwendung von nanoskaligen antischuppenwirkstoffen
NO20011886D0 (no) Utforminger av fexofenadin
NO994626L (no) Substituerte benzamider
ATE196764T1 (de) Kristallform von 5-methylisoxazol-4-carbonsäure- (4-trifluormethyl)-anilid
DE69907146D1 (de) Direkte oxidation von cycloalkanen
IT1304794B1 (it) Miscela di stabilizzanti
DE69531048D1 (de) Verwendung von steroidsulphatase-hemmern
DE69806558D1 (de) Stabilisierung von 3-Isothiazolonlösungen
ATE243197T1 (de) Kristallformen von osanetant
DE69840875D1 (de) Verwaltung von datenstrukturen
ID28032A (id) TRISIKLIK PIPERIDIN-Δ3-SEBAGAI ANTAGONIS-α2
DE69922558D1 (de) Herstellung von Aluminiumoxid
DE69927626D1 (de) Ausführung von Permutationen
DE60006799D1 (de) Oralverabreichbare lösung von prucaloprid
DE60026931D1 (de) Ausrichtung von Ausdrucken

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SANOFI-AVENTIS, PARIS, FR

8339 Ceased/non-payment of the annual fee